Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1-dichloroethene | increases expression | EXP | | 6480464 | vinylidene chloride results in increased expression of MIS18BP1 mRNA | CTD | PMID:26682919 | 1-naphthyl isothiocyanate | increases expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of MIS18BP1 mRNA | CTD | PMID:30723492 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MIS18BP1 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MIS18BP1 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MIS18BP1 mRNA | CTD | PMID:32109520 and PMID:33387578 | 6-propyl-2-thiouracil | increases expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of MIS18BP1 mRNA | CTD | PMID:24780913 | acetamide | increases expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of MIS18BP1 mRNA | CTD | PMID:31881176 | acrylamide | increases expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of MIS18BP1 mRNA | CTD | PMID:28959563 | acrylamide | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of MIS18BP1 mRNA | CTD | PMID:32763439 | aflatoxin B1 | affects expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of MIS18BP1 protein | CTD | PMID:20106945 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of MIS18BP1 mRNA | CTD | PMID:19770486 | aflatoxin M1 | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Aflatoxin M1 results in decreased expression of MIS18BP1 mRNA | CTD | PMID:30928695 | aristolochic acid A | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of MIS18BP1 mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | MIS18BP1 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to MIS18BP1 mRNA] | CTD | PMID:32406909 | azathioprine | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Azathioprine results in decreased expression of MIS18BP1 mRNA | CTD | PMID:22623647 | benzo[a]pyrene | decreases methylation | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of MIS18BP1 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MIS18BP1 mRNA | CTD | PMID:32417428 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 more ... | bis(2-chloroethyl) sulfide | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Mustard Gas results in decreased expression of MIS18BP1 mRNA | CTD | PMID:25102026 | bisphenol A | affects expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of MIS18BP1 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of MIS18BP1 mRNA | CTD | PMID:32145629 | bisphenol A | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of MIS18BP1 mRNA | CTD | PMID:29275510 | bisphenol A | decreases expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of MIS18BP1 mRNA | CTD | PMID:30816183 and PMID:32528016 | bisphenol F | multiple interactions | ISO | MIS18BP1 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of MIS18BP1 gene | CTD | PMID:31601247 | caffeine | affects phosphorylation | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of MIS18BP1 protein | CTD | PMID:35688186 | calcitriol | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of MIS18BP1 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | MIS18BP1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of MIS18BP1 mRNA | CTD | PMID:21592394 | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes and Carbon results in increased expression of MIS18BP1 mRNA | CTD | PMID:25554681 | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of MIS18BP1 mRNA | CTD | PMID:37019170 | cisplatin | increases phosphorylation | EXP | | 6480464 | Cisplatin results in increased phosphorylation of MIS18BP1 protein | CTD | PMID:22006019 | cisplatin | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of MIS18BP1 mRNA | CTD | PMID:27392435 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of MIS18BP1 mRNA | CTD | PMID:25270620 | copper(II) sulfate | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of MIS18BP1 mRNA | CTD | PMID:19549813 | coumarin | increases phosphorylation | ISO | MIS18BP1 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of MIS18BP1 protein | CTD | PMID:35688186 | coumestrol | multiple interactions | ISO | MIS18BP1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | coumestrol | increases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of MIS18BP1 mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of MIS18BP1 mRNA | CTD | PMID:21632981 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of MIS18BP1 mRNA | CTD | PMID:21266533 | dichloroacetic acid | increases expression | EXP | | 6480464 | Dichloroacetic Acid results in increased expression of MIS18BP1 mRNA | CTD | PMID:28962523 | dicrotophos | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of MIS18BP1 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | MIS18BP1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of MIS18BP1 mRNA | CTD | PMID:36227756 | Enterolactone | multiple interactions | ISO | MIS18BP1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MIS18BP1 mRNA | CTD | PMID:19167446 | Erionite | increases expression | EXP | | 6480464 | erionite results in increased expression of MIS18BP1 mRNA | CTD | PMID:29279043 | FR900359 | affects phosphorylation | ISO | MIS18BP1 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of MIS18BP1 protein | CTD | PMID:37730182 | fulvestrant | multiple interactions | ISO | MIS18BP1 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of MIS18BP1 gene | CTD | PMID:31601247 | furan | increases expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | furan results in increased expression of MIS18BP1 mRNA | CTD | PMID:25539665 | geldanamycin | increases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | geldanamycin results in increased expression of MIS18BP1 mRNA | CTD | PMID:26705709 | gentamycin | decreases expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of MIS18BP1 mRNA | CTD | PMID:33387578 | lidocaine | increases expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | Lidocaine results in increased expression of MIS18BP1 mRNA | CTD | PMID:35283115 | mitomycin C | decreases expression | EXP | | 6480464 | Mitomycin results in decreased expression of MIS18BP1 mRNA | CTD | PMID:25270620 | N-Nitrosopyrrolidine | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in decreased expression of MIS18BP1 mRNA | CTD | PMID:32234424 | ochratoxin A | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | ochratoxin A results in decreased expression of MIS18BP1 mRNA | CTD | PMID:30559759 | ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of MIS18BP1 mRNA | CTD | PMID:24336422 | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MIS18BP1 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MIS18BP1 mRNA | CTD | PMID:27106289 and PMID:34911549 | ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of MIS18BP1 mRNA | CTD | PMID:25658374 | paracetamol | decreases expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of MIS18BP1 mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of MIS18BP1 mRNA | CTD | PMID:27153767 | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of MIS18BP1 mRNA | CTD | PMID:23091169 | phenylmercury acetate | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of MIS18BP1 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | MIS18BP1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MIS18BP1 mRNA | CTD | PMID:27188386 | propanal | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | propionaldehyde results in decreased expression of MIS18BP1 mRNA | CTD | PMID:26079696 | quercetin | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of MIS18BP1 mRNA | CTD | PMID:21632981 | quercetin | increases phosphorylation | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Quercetin results in increased phosphorylation of MIS18BP1 protein | CTD | PMID:35688186 | resveratrol | multiple interactions | ISO | MIS18BP1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with Resveratrol] results in increased expression of MIS18BP1 mRNA and [Plant Extracts co-treated with Resveratrol] results in increased expression of MIS18BP1 mRNA | CTD | PMID:19167446 and PMID:23557933 | SB 431542 | multiple interactions | ISO | MIS18BP1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of MIS18BP1 mRNA | CTD | PMID:29341224 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MIS18BP1 mRNA | CTD | PMID:17998272 | sunitinib | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of MIS18BP1 mRNA | CTD | PMID:31533062 | testosterone | multiple interactions | ISO | MIS18BP1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of MIS18BP1 mRNA | CTD | PMID:21592394 | testosterone | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of MIS18BP1 mRNA | CTD | PMID:21592394 and PMID:33359661 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of MIS18BP1 mRNA | CTD | PMID:17484886 and PMID:31919559 | thimerosal | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of MIS18BP1 mRNA | CTD | PMID:27188386 | thioacetamide | increases expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of MIS18BP1 mRNA | CTD | PMID:34492290 | tremolite asbestos | increases expression | EXP | | 6480464 | tremolite results in increased expression of MIS18BP1 mRNA | CTD | PMID:29279043 | trichloroethene | decreases expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of MIS18BP1 mRNA | CTD | PMID:33387578 | trichostatin A | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of MIS18BP1 mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | ISO | MIS18BP1 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MIS18BP1 mRNA | CTD | PMID:27188386 | trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of MIS18BP1 mRNA | CTD | PMID:19042947 | trovafloxacin | decreases expression | EXP | | 6480464 | trovafloxacin results in decreased expression of MIS18BP1 mRNA | CTD | PMID:35537566 | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of MIS18BP1 mRNA | CTD | PMID:30912803 | valproic acid | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of MIS18BP1 mRNA | CTD | PMID:23179753 and PMID:28001369 | valproic acid | decreases expression | ISO | Mis18bp1 (Rattus norvegicus) | 6480464 | Valproic Acid results in decreased expression of MIS18BP1 mRNA | CTD | PMID:35594946 | vorinostat | decreases expression | ISO | MIS18BP1 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of MIS18BP1 mRNA | CTD | PMID:27188386 | |